{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T07:05:43Z","timestamp":1774940743856,"version":"3.50.1"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Lupus nephritis (LN) represents one of the most frequent and severe manifestations of systemic lupus erythematosus (SLE), highlighting an urgent need for novel non-invasive approaches to improve its diagnosis and clinical monitoring.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To characterize serum and urinary metabolomic profiles, together with urinary cytokine expression, in patients with lupus nephritis (LN) across the clinical spectrum from active disease, post-induction response, and sustained remission.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We enrolled 62 patients fulfilling the 2019 ACR\/EULAR SLE criteria, divided into three groups: active LN (n=21), post-induction responders at 6 months (n=21), and sustained responders with \u22652 years of remission (n=20). Untargeted metabolomic profiling of serum and urine was performed using GC-MS, and urinary cytokines were measured by luminometry. Statistical analyses included Kruskal-Wallis tests and multinomial logistic regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Median age was 36 years; 87% were female. Twelve serum metabolites and ten urinary metabolites differed significantly across groups. Active LN patients showed increased urinary threonate and elevated cytokines (15 out of 17 measured, including IL-10). Serum glycerol was significantly higher in post-induction responders compared to sustained responders, while urinary sucrose was lower in this group. Logistic regression identified urinary threonate as discriminative for active LN, whereas serum glycerol (OR 1.05, 95% CI 1.048\u20131.050) and urinary sucrose (OR 0.98, 95% CI 0.9802\u20130.981) differentiated post-induction from sustained response. Increased urinary IL-10 was strongly associated with active LN, while G-CSF discriminated post-induction from sustained responders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion and conclusions<\/jats:title>\n                    <jats:p>The combined analysis of serum\/urinary metabolomic profiles and urinary cytokines provides discriminatory power to differentiate active LN from remission states, supporting their potential role as non-invasive biomarkers for diagnosis and treatment monitoring.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1787160","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T05:33:53Z","timestamp":1774935233000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrated metabolomic and cytokine profiling reveals biomarkers across the clinical spectrum of lupus nephritis"],"prefix":"10.3389","volume":"17","author":[{"given":"Mariana","family":"Jim\u00e9nez-Tirado","sequence":"first","affiliation":[{"name":"Departamento de Inmunolog\u00eda y Reumatolog\u00eda, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n","place":["Mexico City, Mexico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karina","family":"Santana-De Anda","sequence":"additional","affiliation":[{"name":"Departamento de Inmunolog\u00eda y Reumatolog\u00eda, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n","place":["Mexico City, Mexico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauricio","family":"Arvizu-Hern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Departamento de Nefrolog\u00eda y Metabolismo Mineral, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n","place":["Mexico City, Mexico"]},{"name":"Escuela de Medicina y Ciencias de la Salud, Instituto Tecnol\u00f3gico y de Estudios Superiores de Monterrey","place":["Mexico City, Mexico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer Tiar\u00e9","family":"Balderas-Miranda","sequence":"additional","affiliation":[{"name":"Departamento de Inmunolog\u00eda y Reumatolog\u00eda, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n","place":["Mexico City, Mexico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Alcal\u00e1-Carmona","sequence":"additional","affiliation":[{"name":"Departamento de Inmunolog\u00eda y Reumatolog\u00eda, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n","place":["Mexico City, Mexico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yatzil","family":"Reyna-Ju\u00e1rez","sequence":"additional","affiliation":[{"name":"Departamento de Inmunolog\u00eda y Reumatolog\u00eda, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n","place":["Mexico City, Mexico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David Eduardo","family":"Meza-S\u00e1nchez","sequence":"additional","affiliation":[{"name":"Red de Apoyo a la Investigaci\u00f3n, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n and Universidad Nacional Aut\u00f3noma de M\u00e9xico","place":["Mexico City, Mexico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Mej\u00eda-Dom\u00ednguez","sequence":"additional","affiliation":[{"name":"Red de Apoyo a la Investigaci\u00f3n, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n and Universidad Nacional Aut\u00f3noma de M\u00e9xico","place":["Mexico City, Mexico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Carlos","family":"Paez-Franco","sequence":"additional","affiliation":[{"name":"Red de Apoyo a la Investigaci\u00f3n, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n and Universidad Nacional Aut\u00f3noma de M\u00e9xico","place":["Mexico City, Mexico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilda","family":"S\u00e1nchez-Vidal","sequence":"additional","affiliation":[{"name":"Red de Apoyo a la Investigaci\u00f3n, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n and Universidad Nacional Aut\u00f3noma de M\u00e9xico","place":["Mexico City, Mexico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imelda Cecilia","family":"Zarzoza-Mendoza","sequence":"additional","affiliation":[{"name":"Red de Apoyo a la Investigaci\u00f3n, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n and Universidad Nacional Aut\u00f3noma de M\u00e9xico","place":["Mexico City, Mexico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Luis","family":"Maravillas-Montero","sequence":"additional","affiliation":[{"name":"Departamento de Medicina Molecular y Bioprocesos, Instituto de Biotecnolog\u00eda, Universidad Nacional Aut\u00f3noma de M\u00e9xico","place":["Cuernavaca, Mexico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Jiram","family":"Torres-Ruiz","sequence":"additional","affiliation":[{"name":"Departamento de Inmunolog\u00eda y Reumatolog\u00eda, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n","place":["Mexico City, Mexico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"G\u00f3mez-Mart\u00edn","sequence":"additional","affiliation":[{"name":"Departamento de Inmunolog\u00eda y Reumatolog\u00eda, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n","place":["Mexico City, Mexico"]},{"name":"Red de Apoyo a la Investigaci\u00f3n, Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n and Universidad Nacional Aut\u00f3noma de M\u00e9xico","place":["Mexico City, Mexico"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2012.08.018","article-title":"Lupus nephritis: A critical review","volume":"12","author":"Borchers","year":"2012","journal-title":"Autoimmun Rev"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-019-0141-9","article-title":"Lupus nephritis","volume":"6","author":"Anders","year":"2020","journal-title":"Nat Rev Dis Primer"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1186\/s42047-023-00136-y","article-title":"Metabolomics and biomarkers for lupus nephritis \u2013 a systematic review","volume":"6","author":"Barone","year":"2023","journal-title":"Surg Exp Pathol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.04.005","article-title":"Metabolic pathways in immune cell activation and quiescence","volume":"38","author":"Pearce","year":"2013","journal-title":"Immunity"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/srep35309","article-title":"NMR based serum metabolomics reveals a distinctive signature in patients with Lupus Nephritis","volume":"6","author":"Guleria","year":"2016","journal-title":"Sci Rep"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1177\/0961203320918011","article-title":"Nuclear magnetic resonance\u2013based targeted profiling of urinary acetate and citrate following cyclophosphamide therapy in patients with lupus nephritis","volume":"29","author":"Ganguly","year":"2020","journal-title":"Lupus"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2024.09.007","article-title":"Urinary biomarkers for active Lupus Nephritis that have survived independent validation across cohorts","volume":"106","author":"Vodehnal","year":"2024","journal-title":"Kidney Int"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e0240942","DOI":"10.1371\/journal.pone.0240942","article-title":"The utility of urinary biomarker panel in predicting renal pathology and treatment response in Chinese lupus nephritis patients","volume":"15","author":"Liu","year":"2020","journal-title":"PloS One"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/art.40930","article-title":"2019 European league against rheumatism\/American college of rheumatology classification criteria for systemic lupus erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/acr.24221","article-title":"Measures of adult systemic lupus erythematosus: disease activity and damage","volume":"72","author":"Arora","year":"2020","journal-title":"Arthritis Care Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2019.10.017","article-title":"Update on lupus nephritis: core curriculum 2020","volume":"76","author":"Parikh","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13075-024-03275-z","article-title":"Longitudinal patterns and predictors of response to standard-of-care therapy in lupus nephritis: data from the Accelerating Medicines Partnership Lupus Network","volume":"26","author":"Izmirly","year":"2024","journal-title":"Arthritis Res Ther"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-022-06258-0","article-title":"Renal response and its predictive factors of lupus nephritis: a 2-year real-world study of 56 hospital-based patients","volume":"41","author":"Du","year":"2022","journal-title":"Clin Rheumatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2024.01.016","article-title":"Effect of sustained clinical remission on the risk of lupus flares and impaired kidney function in patients with lupus nephritis","volume":"9","author":"Gatto","year":"2024","journal-title":"Kidney Int Rep"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/0471142727.mb3004s114","article-title":"Metabolomics by gas chromatography\u2013mass spectrometry: combined targeted and untargeted profiling","volume":"114","author":"Fiehn","year":"2016","journal-title":"Curr Protoc Mol Biol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3390\/metabo10090376","article-title":"Towards standardization of data normalization strategies to improve urinary metabolomics studies by GC\u00d7GC-TOFMS","volume":"10","author":"Nam","year":"2020","journal-title":"Metabolites"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2009.01.007","article-title":"Normalization strategies for metabonomic analysis of urine samples","volume":"877","author":"Warrack","year":"2009","journal-title":"J Chromatogr B"},{"key":"B18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s11306-023-02086-8","article-title":"Evaluation of normalization strategies for GC-based metabolomics","volume":"20","author":"Nam","year":"2024","journal-title":"Metabolomics"},{"key":"B19","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.plipres.2017.07.002","article-title":"Implications of glycerol metabolism for lipid production","volume":"68","author":"Xue","year":"2017","journal-title":"Prog Lipid Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.967371","article-title":"Metabolic profiling reveals new serum signatures to discriminate lupus nephritis from systemic lupus erythematosus","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2021.101367","article-title":"Serum integrative omics reveals the landscape of human diabetic kidney disease","volume":"54","author":"Liu","year":"2021","journal-title":"Mol Metab"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1042\/bst0030518","article-title":"The Urinary Excretion of Glycollic Acid and Threonic Acid by Xylitol-Infused Patients and their Relationship to the Possible Role of \u2018Active Glycolaldehyde\u2019 in the Transketolase Reaction in vivo","volume":"3","author":"Chalmers","year":"1975","journal-title":"Biochem Soc Trans"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2022.109057","article-title":"Integration of metabolomics and lipidomics reveals serum biomarkers for systemic lupus erythematosus with different organs involvement","volume":"241","author":"Zhang","year":"2022","journal-title":"Clin Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.665661","article-title":"Comprehensive metabolic signature of renal dysplasia in children. A multiplatform metabolomics concept","volume":"8","author":"Macioszek","year":"2021","journal-title":"Front Mol Biosci"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27132","article-title":"Distinct metabolomic signature in cerebrospinal fluid in early parkinson\u2019s disease","volume":"32","author":"Trezzi","year":"2017","journal-title":"Mov Disord"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e0228989","DOI":"10.1371\/journal.pone.0228989","article-title":"Urinary chemical fingerprint left behind by repeated NSAID administration: Discovery of putative biomarkers using artificial intelligence","volume":"15","author":"Broughton-Neiswanger","year":"2020","journal-title":"PloS One"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-04-0827","article-title":"Urinary sucrose and fructose as biomarkers for sugar consumption","volume":"14","author":"Tasevska","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.970906","article-title":"IL-10 revisited in systemic lupus erythematosus","volume":"13","author":"Biswas","year":"2022","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22031347","article-title":"Dual role of interleukin-10 in murine NZB\/W F1 lupus","volume":"22","author":"Amend","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1917834117","article-title":"Evidence for a pathogenic role of extrafollicular, IL-10\u2013producing CCR6+ B helper T cells in systemic lupus erythematosus","volume":"117","author":"Facciotti","year":"2020","journal-title":"Proc Natl Acad Sci"},{"key":"B31","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12882-016-0380-x","article-title":"Granulocyte colony-stimulating factor treatment ameliorates lupus nephritis through the expansion of regulatory T cells","volume":"17","author":"Yan","year":"2016","journal-title":"BMC Nephrol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.163.9.5125","article-title":"Granulocyte-colony stimulating factor treatment of lupus autoimmune disease in MRL- lpr\/lpr mice","volume":"163","author":"Zavala","year":"1999","journal-title":"J Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1039\/C1AN15605E","article-title":"Modern analytical techniques in metabolomics analysis","volume":"137","author":"Zhang","year":"2012","journal-title":"Analyst"},{"key":"B34","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/mas.20108","article-title":"Mass spectrometry-based metabolomics","volume":"26","author":"Dettmer","year":"2007","journal-title":"Mass Spectrom Rev."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1787160\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T05:33:55Z","timestamp":1774935235000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1787160\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":34,"alternative-id":["10.3389\/fimmu.2026.1787160"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1787160","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]},"article-number":"1787160"}}